2020 Vision: making England s HIV prevention response the best in the world
|
|
- Suzan Owens
- 6 years ago
- Views:
Transcription
1 DISCUSSION PAPER 2020 Vision: making England s HIV prevention response the best in the world Introduction Effective HIV prevention makes good public health and economic sense. HIV remains one of the fastest-growing serious health conditions in England. Every HIV infection prevented saves the State around 280,000 i and saves a life from being damaged. Many of us play a role in the fight against HIV and this report is intended to stimulate debate about our personal, professional and communal responsibilities to stop HIV. It sets out strategies for the years ahead, some new and some needing renewal, and highlights ways that we can all work together to build the best HIV prevention response in the world. What s working well? England has much to be proud of in its response to HIV. In particular: The volume of HIV testing done each year continues to increase ii. We already have one of the highest levels of people with diagnosed HIV in care and on treatment, most with undetectable viral loads iii, thanks to the world-class care provided by the NHS and its skilled clinicians. Infections among the group at greatest risk, gay men, appear to have been stable in recent years. Condom use has saved many thousands from HIV infection and continues to be sustained by many people. Mother-to-child HIV transmission is at almost zero as a result of universal antenatal screening iv. 1 We have some of the lowest levels of HIV among injecting drug users of any nation in Europe as a result of sustained harm reduction programmes v. We have a world-leading HIV public health surveillance system giving better information about patterns of HIV need than most other countries. Where do we need to improve? England does, though, have a number of areas in which its response needs to improve. In particular: Levels of undiagnosed HIV remain far too high, especially considering that the majority of ongoing HIV transmission occurs from those with undiagnosed HIV. Partner notification levels are too low, meaning that too many people are not notified that they may have been exposed to HIV. We need to challenge and change sexual risk-taking behaviour in all communities at heightened risk of HIV transmission. In too many of its cities, England lacks the co-ordinated city-wide approach to HIV prevention seen elsewhere, and this is being exacerbated by local funding cuts to HIV prevention work. We need to broaden the understanding of HIV and its diagnosis among all non-specialist healthcare services. HIV stigma still plays a large part in reluctance both to test and to disclose a positive diagnosis, leading to poor personal and public health.
2 The UK is the sixth wealthiest nation in the world and has one of the best health systems anywhere in the world. As such, it is within our power to overcome these challenges. We need to re-energise and renew our approach to tackling HIV across England. We believe a new ambition is needed for HIV prevention in England - nothing less than having the best HIV prevention response anywhere in the world. Our ambition for England We believe that a new ambition for HIV prevention in England is needed: A 50% reduction in the numbers of people with undiagnosed HIV (10,000 people). A 125% increase in the number of HIV tests undertaken annually by people at greatest risk (an extra 250,000 tests a year). 75% of all people with HIV to be on HIV treatment and uninfectious. A measurable increase in condom use and harm reduction measures among those at greatest HIV risk. Tackling the social determinants of poor sexual health among those individuals and communities at greatest HIV risk. These targets would achieve our vision of substantially reducing the level of HIV transmission which occurs in England by A 50% reduction in people with undiagnosed HIV (10,000 people) By 2020, no more than 11% of those infected with HIV in England should remain undiagnosed. Exploring next generation approaches to diagnosing HIV such as viral load testing in high prevalence populations to diagnose those in primary infection. Maximising efficacy, affordability and availability of HIV self-testing so that those who want to pay for an HIV test at home are able to do so. Establishing new digital approaches to partner notification which empower people to maximise personal responsibility for their own sexual health and that of their partners. Expanded access to HIV testing for those at greatest HIV risk, including free at the point of use HIV home sampling via multiple routes and expanded HIV testing by voluntary organisations and community health services. HIV testing needs to be expanded in settings such as businesses and churches used by those at greatest risk eg, gay men and migrants from high prevalence countries. Further expanded HIV testing in general practice and significantly expanded hospital HIV testing through embedding this as normal practice in general medical admissions and relevant outpatient services. HIV testing as a routine, opt-out part of all sexual health service provision. Existing models of partner notification should be extended to increase uptake. More than a fifth of people with HIV are currently undiagnosed vi. This group accounts for at least two thirds of all HIV transmission in England. People diagnosed late with HIV are at greater risk of avoidable morbidity and mortality vii. 2
3 A 125% increase in the number of HIV tests undertaken annually by people at greatest risk (an extra 250,000 tests a year) Reducing levels of undiagnosed HIV as described above requires a step change in the volume of HIV tests undertaken annually by those at greatest risk, and a step change in access to testing. It also requires a culture shift in those communities so that regular and routine testing becomes a cultural norm. An extra 250,000 HIV tests should be undertaken annually within five years, focused on those communities at greatest HIV risk. Investing an extra 20 million per year across England as a whole to enable an extra 250,000 HIV tests to be undertaken annually. Relative to the lifetime and annual costs of HIV treatment for those infected with HIV each year viii, the 20 million required to expand HIV testing is a drop in the ocean, and represents a very significant return on investment. Establishing recall and support mechanisms for people who test HIV negative, to encourage regular and repeat testing and to provide support to help people stay HIV negative. Challenging the current costs of testing interventions and maximising the use of those which are most cost-effective. Co-ordinated local HIV prevention programmes which make HIV tests widely available, get full engagement from all organisations and businesses in contact with HIV high risk groups and which provide strong local leadership. Changing the culture of testing in communities at greatest HIV risk, through social marketing and information provision, to persuade more people to test and then to go on to test regularly. Establishing integrated local and national HIV prevention programmes which co-ordinate the delivery of interventions which heavily promote regular HIV testing. Access to GPs and other NHS services for people of uncertain immigration status. 75% of people with HIV to be on HIV treatment and uninfectious Treatment as prevention (TasP) is a key strategy for HIV prevention; by reducing infectivity among people with HIV it reduces the likelihood of HIV being passed on. It is also key to individual health, enabling most people to remain relatively healthy and, if diagnosed early, achieve a near normal life expectancy. 75% of people with HIV retained in care, on treatment, and uninfectious by England is performing well, with 61% of those with HIV on treatment ix and uninfectious, but we could do better. Ensuring that everyone diagnosed with HIV, regardless of location, is supported into care and followed up. This should include case management for people vulnerable to losing contact with HIV services and should ensure full access for undocumented migrants. New approaches to active case management to make sure no one with HIV loses contact with HIV services. Exploration of new next generation approaches to HIV treatment such as encouraging greater take-up of treatment irrespective of CD4 count x. Positive Prevention programmes, aimed at helping people with HIV optimise their health and establish a new positive prevention care pathway containing all services needed, such as sexual health, alcohol/ drug use and mental wellbeing. 3
4 Access to information and advocacy for people who are newly diagnosed with HIV to maximise their knowledge and motivation to begin treatment when indicated by BHIVA (British HIV Association) guidelines xi, and to understand the preventive benefits of HIV treatment. Delivery of peer and social marketing information and support for people in care, through a variety of settings and channels, to encourage appropriate take-up of treatment. Maintaining a network of high quality NHS HIV treatment centres across England, to ensure the capacity and capability to support the increasing numbers of people diagnosed as a result of the changes described elsewhere in this paper. A measurable increase in condom use and harm reduction measures among those at greatest HIV risk Condom use is the most effective means of preventing HIV transmission with research suggesting that, in the UK alone, condom use has prevented 80,000 infections since the start of the epidemic. It is therefore important that condom use is both sustained and wherever possible increased. Other approaches to reducing risk behaviour, such as Post-exposure prophylaxis (PEP), needle exchanges and sexual behavioural interventions, also have an important role to play in preventing HIV transmission. An increase by at least 10% in current levels of condom use among men who have sex with men (MSM) and increased acceptability and use of condoms among heterosexuals. Everyone at raised risk of acquiring HIV should understand this and be able to obtain appropriate help to manage their risk. Challenging the culture of non-condom use as being exciting or transgressive among some groups of people. 4 Expanding access to Pre-exposure prophylaxis (PrEP) for those with the ability to benefit, as the evidence base becomes fully established. Ensuring the availability of free or low-cost condom programmes for those at greatest HIV risk. The delivery of social marketing work to both encourage use of condoms and emphasise community norms about condom use. Access to PEP. Access to structured behaviour change interventions linked to clinical and community HIV services, so that people with the highest HIV risk behaviours are supported to change them. The development of new bio-medical interventions, eg, microbicides and vaccines that reduce the likelihood of HIV infection. Active encouragement of a broader range of risk-reduction approaches such as disclosure of HIV status. Maintaining a network of needle exchange and harm reduction services for injecting drug users. Tackling the social determinants of poor sexual health among those individuals and communities at greatest HIV risk HIV acquisition is driven not only by direct risk-taking behaviour but also by the social and personal conditions which impel and encourage that risk-taking. Moreover, community norms, perceived peer expectations and knowledge levels can operate to support or hinder HIV prevention and risk-taking. HIV transmission is dependent upon both individual risk-taking and relative risk levels in particular populations. Drug (including alcohol) use and mental health are particularly key determinants of risk for many people acquiring HIV or taking the risks which lead to poor sexual health.
5 s An increased knowledge of sexual health and increased confidence in sexual situations, decreased levels of depression or mental ill-health and a decrease in problematic alcohol or drug use within communities at greatest risk of HIV. Key influencers in the most at-risk populations are involved in and informed about HIV prevention and sexual health promotion and those profiting from those populations are active in supporting measures to reduce transmission and increase understanding of HIV. People with diagnosed HIV are equipped to manage their condition and prevent further transmission. Mandatory Sex and Relationships Education (SRE) in schools that covers sexuality, HIV and good sexual health and self-esteem. Integrated support within clinic and community settings for sexual health, mental health and dependency issues to be understood and managed by people living with HIV. Challenging community stigma around these key issues in order to support individual help-seeking behaviours. Developing corporate social responsibility expectations of those businesses profiting from communities at greater risk. In particular codes of conduct in supporting sexual health within those commercial social activities where risk may be heightened, including bars, saunas and online dating sites. A code of conduct for labelling films purporting to show condomless sex and aimed at HIV high-risk groups, reminding them of the risks. Online and telephone services which support peer-to-peer and specialist support for anyone, anywhere in England, to obtain anonymised help with sex, drugs and mental health. Access to specialist drug services focusing on recreational ( club drug ) use among MSM, working both to minimise harm and to reduce levels of problematical drug use. Active participation of people, groups and key influencers from the most at-risk communities in the development and delivery of HIV campaigns and services. Sustained community involvement, engagement and organisational development to increase our collective capacity to contribute to reducing HIV infections. Local, regional and national media and influencing work to improve public understanding and secure public and political support for HIV prevention and sexual health promotion. Reducing HIV infections year-on-year in England: success by 2020 The overarching goal of the measures suggested above should be to achieve a reduction in the level of HIV transmission occurring every year in England. By 2020, this should have significantly altered the treatment cascade and raised the percentages of people diagnosed, in care, on treatment and uninfectious to a degree that will help us to turn the tide on HIV in this country. 5
6 The achievement of this would enable: Significant benefits in health for people with HIV and those in the communities at greatest risk. Significant public health benefits through reduced HIV transmission. Significant cost savings for the taxpayer by reducing the costs of HIV for NHS and Local Government funders. With concerted effort both locally and nationally, these benefits are within our grasp. Doing so would give us the best HIV prevention response anywhere in the world, would showcase the strength of public health in England, and above all would transform the lives of tens of thousands of people, many of them in marginalised communities. i Public Health England, HIV epidemiology in London: 2011 data. ii Agahizu et al, HIV in the United Kingdom 2013 report: data to end Public Health England, London. iii Ibid. iv Ibid. v Global Report: UNAIDS report on the global AIDS epidemic vi Agahizu et al, HIV in the United Kingdom 2013 report: data to end Public Health England, London. vii Ibid. viii Gazzard, B. Moecklinghoff, C. and Hill, A., New strategies for lowering the costs of antiretroviral treatment and care for people with HIV/AIDS in the United Kingdom. ClinicoEconomics and Outcomes Research, 4: ix Agahizu et al, HIV in the United Kingdom 2013 report: data to end Public Health England, London. x Gazzard, B. Moecklinghoff, C. and Hill, A., New strategies for lowering the costs of antiretroviral treatment and care for people with HIV/AIDS in the United Kingdom. ClinicoEconomics and Outcomes Research, 4: xi British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy HIV Medicine (2014), 15 (Suppl. 1),
Tackling the spread of HIV in the UK
Tackling the spread of HIV in the UK Investment in HIV prevention makes good economic sense. Every HIV infection prevented saves the State some 280,000 and saves a human life from being blighted. The UK
More informationViiV Healthcare s Position on Prevention in HIV
ViiV Healthcare s Position on Prevention in HIV ViiV Healthcare is a company 100% committed to HIV, and we are always looking to move beyond the status quo and find new ways of navigating the challenges
More informationImproving outcomes The UK s achievements in managing and preventing the HIV epidemic and how we should approach public health priorities
Improving outcomes The UK s achievements in managing and preventing the HIV epidemic and how we should approach public health priorities Professor Kevin Fenton Senior Advisor, Public Health England Director,
More informationMid-term Review of the UNGASS Declaration of. Commitment on HIV/AIDS. Ireland 2006
Mid-term Review of the UNGASS Declaration of Commitment on HIV/AIDS Ireland 2006 Irish Role in Global Response Just as the HIV/AIDS epidemic is a global threat, addressing the challenge of the epidemic
More informationVictorian AIDS Council Gay Men s Health Centre
Victorian AIDS Council Gay Men s Health Centre including the Positive Living Centre VAC Reg. No. A 3609 GMHC Reg No. A0010550F VAC ABN 52 907 644 835 GMHC ABN 87 652 472 253 AUSTRALIAN GOVERNMENT DEPARTMENT
More informationHIV in the United Kingdom
HIV in the United Kingdom Valerie Delpech and Alison Brown on behalf of the HIV and AIDS Reporting Section National Infection Service Public Health England Released 15 December 2017 Undetectable=Untransmittable
More informationUNAIDS 2016 THE AIDS EPIDEMIC CAN BE ENDED BY 2030 WITH YOUR HELP
UNAIDS 2016 THE AIDS EPIDEMIC CAN BE ENDED BY 2030 WITH YOUR HELP WHY UNAIDS NEEDS YOUR SUPPORT Over the past 35 years, HIV has changed the course of history. The massive global impact of AIDS in terms
More informationColloque scientifique : L économie de la prévention Analysis of Cost-Effectiveness of HIV Prevention
Colloque scientifique : L économie de la prévention Analysis of Cost-Effectiveness of HIV Prevention Julia Walsh MD, MSc Professor School of Public Health University of California Berkeley Objectives Cost-effectiveness
More informationHIV in the UK: Changes and Challenges; Actions and Answers The People Living With HIV Stigma Survey UK 2015 London STIGMA SURVEY UK 2015
HIV in the UK: Changes and Challenges; Actions and Answers The People Living With HIV Stigma Survey UK 2015 London STIGMA SURVEY UK 2015 LONDON The landscape for people living with HIV in the United Kingdom
More informationHIV transmission in the UK within Black African communities: how common is it and how do we prevent it? Dr Valerie Delpech
HIV transmission in the UK within Black African communities: how common is it and how do we prevent it? Dr Valerie Delpech We gratefully acknowledge persons living with HIV, clinicians, health advisors,
More informationDo you find this clinical policy or service specification clear and comprehensive?
Service specification for HIV: British HIV Association response Version 3 25012013 Do you find this clinical policy or service specification clear and comprehensive? No. There are a number of areas that
More informationIFMSA Policy Statement Ending AIDS by 2030
IFMSA Policy Statement Ending AIDS by 2030 Proposed by IFMSA Team of Officials Puebla, Mexico, August 2016 Summary IFMSA currently acknowledges the HIV epidemic as a major threat, which needs to be tackled
More informationProviding Good Care to People Living with HIV
National Ambulance LGBT Network Providing Good Care to People Living with HIV An Ambulance Service Resource Pack Supporting Lesbian, Gay, Bisexual, Trans staff, patients and communities A partnership of
More informationLinkages between Sexual and Reproductive Health and HIV
Linkages between Sexual and Reproductive Health and HIV Manjula Lusti-Narasimhan Department of Reproductive Health and Research World Health Organization The HIV pandemic 25 years 1981 2006 Rationale for
More informationWorld Health Organization. A Sustainable Health Sector
World Health Organization A Sustainable Health Sector Response to HIV Global Health Sector Strategy for HIV/AIDS 2011-2015 (DRAFT OUTLINE FOR CONSULTATION) Version 2.1 15 July 2010 15 July 2010 1 GLOBAL
More informationEliminating Viral Hepatitis in Australia: Where are we in 2017?
This document was prepared by Hepatitis Australia in consultation with a variety of stakeholders working in the areas of hepatitis B and hepatitis C in Australia. This included people involved in primary
More informationImplementation of testing (and other interventions along the Continuum of Care)
Implementation of testing (and other interventions along the Continuum of Care) Jonathan Mermin, MD, MPH National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention U.S. Centers for Disease Control
More informationHIV in the UK: Changes and Challenges; Actions and Answers The People Living With HIV Stigma Survey UK 2015 Scotland STIGMA SURVEY UK 2015
HIV in the UK: Changes and Challenges; Actions and Answers The People Living With HIV Stigma Survey UK 2015 Scotland STIGMA SURVEY UK 2015 SCOTLAND The landscape for people living with HIV in the United
More informationUNGASS COUNTRY PROGRESS REPORT SINGAPORE
UNGASS COUNTRY PROGRESS REPORT SINGAPORE Submission date: 14 March 2008 Reporting period: January 2006 December 2007 I. Overview of the HIV/AIDS epidemic Singapore is categorized as a low-prevalence epidemic.
More information2016 United Nations Political Declaration on Ending AIDS sets world on the Fast-Track to end the epidemic by 2030
S T A T E M E N T 2016 United Nations Political Declaration on Ending AIDS sets world on the Fast-Track to end the epidemic by 2030 World leaders commit to reach three goals and 20 new Fast-Track Targets
More information>Hepatitis NSW will continue to
Continued Equal Treatment Access to hepatitis C medicines KURT SAYS Everyone with viral hepatitis deserves equal access to treatment. Thankfully Australians can access hepatitis C treatment before they
More information26 th Meeting of the UNAIDS Programme Coordinating Board Geneva, Switzerland June 2010
3 June 2010 26 th Meeting of the UNAIDS Programme Coordinating Board Geneva, Switzerland 22-24 June 2010 Next Programme Coordinating Board meetings Document prepared by the Programme Coordinating Board
More informationACCELERATING HIV COMBINATION PREVENTION HIV COMBINATION PREVENTION INTERVENTIONS
ACCELERATING HIV COMBINATION PREVENTION HIV COMBINATION PREVENTION INTERVENTIONS Dr T Chidarikire HIV PREVENTION STRATEGIES 13 JUNE 2017 1 Purpose To share the Health Sector HIV Prevention Strategy with
More informationConnecting the Community. Advancing the HIV Response in Baltimore and Jackson.
Connecting the Community. Advancing the HIV Response in Baltimore and Jackson. Connecting the Community. Advancing the HIV Response in Baltimore and Jackson. The Motivation: What the Numbers Say ACCELERATE!
More informationGovernment of Canada Federal AIDS Initiative Milestones
HIV in Canada: Trends and Issues for Advancing Prevention, Care, Treatment and Support Through Knowledge Exchange Michael R Smith, Senior Policy Advisor, Programs and Coordination Division, Centre for
More informationSex on premises venue code of practice
Sex on premises venue code of practice Introduction Sex on premises venues include sex clubs, backrooms, saunas and other commercial venues where patrons pay to enter to meet and have sex with other customers.
More informationProgram to control HIV/AIDS
90-90-90 Program to control HIV/AIDS Hamid Sharifi Associate Professor in Epidemiology [sharifihami@gmail.com] 1 Targets for ending the AIDS epidemic 2 New HIV infections in low- and middle-income countries,
More informationFPA Sri Lanka Policy: Men and Sexual and Reproductive Health
FPA Sri Lanka Policy: Men and Sexual and Reproductive Health Introduction 1. FPA Sri Lanka is committed to working with men and boys as clients, partners and agents of change in our efforts to meet the
More informationWHO Global Health Sector Strategies HIV; Viral Hepatitis; Sexually Transmitted Infections
Common structure Universal Health Coverage SDGs Cascade of services Vision, Goals and Targets Costed Actions WHO Global Health Sector Strategies 2016-2021 HIV; Viral Hepatitis; Sexually Transmitted Infections
More informationNICE guideline Published: 1 December 2016 nice.org.uk/guidance/ng60
HIV testing: increasing uptake among people who may have undiagnosed HIV NICE guideline Published: 1 December 2016 nice.org.uk/guidance/ng60 NICE 2018. All rights reserved. Subject to Notice of rights
More informationHIV Prevention Prioritization & Implementation Brief: Kaduna State
HIV Prevention Prioritization & Implementation Brief: Kaduna State Introduction The HIV epidemic in Nigeria is complex, with substantial heterogeneity in HIV prevalence across different regions and diverse
More informationHigh Impact HIV Prevention Services and Best Practices
High Impact HIV Prevention Services and Best Practices David W. Purcell, JD, PhD Deputy Director for Behavioral and Social Science Division of HIV/AIDS Prevention Centers for Disease Control and Prevention
More informationEmma Zurowski PaSH Programme Lead BHA for Equality. Peter Bampton Sexual Health Lead LGBT Foundation. gmpash.org.uk.
Emma Zurowski PaSH Programme Lead BHA for Equality Peter Bampton Sexual Health Lead LGBT Foundation gmpash.org.uk 1 to 1 Interventions Group Work Interventions Testing Outreach Website Counselling for
More informationZero HIV infections Zero HIV deaths Zero HIV stigma. Stephanie Cohen, MD, MPH on behalf of the Getting to Zero Consortium
Zero HIV infections Zero HIV deaths Zero HIV stigma Stephanie Cohen, MD, MPH on behalf of the Getting to Zero Consortium Number of New HIV Diagnoses Overall decline in new HIV diagnoses and death in San
More informationHIV Treatment as Prevention (TasP) Guideline and protocol
HIV Treatment as Prevention (TasP) Guideline and protocol Who can use this guidance? This guidance is for clinical staff working within the HIV and sexual health services, NHS Tayside. Staff using this
More informationWhen PrEP fails. Laura Waters MD FRCP Mortimer Market Centre London
When PrEP fails Laura Waters MD FRCP Mortimer Market Centre London www.aidsunited.org PrEP works If people at risk take it If it s taken in the right way If it s available Commissioned/licensed Affordable
More informationHIV, HBV and HCV testing policy experiences and lessons learned.
HIV, HBV and HCV testing policy experiences and lessons learned. Contents HIV and viral hepatitis: distinct epidemics at different stages of evolution Epidemiology: transmission, prevalence, incidence
More informationTechnical Guidance Note for Global Fund HIV Proposals
Technical Guidance Note for Global Fund HIV Proposals UNAIDS I World Health Organization I 2011 Rationale for including this activity in the proposal The World Health Organization (WHO), the Joint United
More informationBUDGET AND RESOURCE ALLOCATION MATRIX
Strategic Direction/Function ILO Strengthened capacity of young people, youth-led organizations, key service providers and partners to develop, implement, monitor and evaluate HIV prevention programmes
More informationPromoting the health and wellbeing of gay, bisexual and other men who have sex with men. Summary Document
Promoting the health and wellbeing of gay, bisexual and other men who have sex with men Summary Document 1 Health and wellbeing of men who have sex with men This summary sets out Public Health England
More informationNO DISCLOSURES TO DECLARE
NO DISCLOSURES TO DECLARE 1 Why is it important for us to know about the future of these service 2 Total number of people living with HIV in UK estimated to be 97,500-105,700 (PHE) 2017) Total new infections
More informationThe National perspective Public Health England s vision, mission and priorities
The National perspective Public Health England s vision, mission and priorities Dr Ann Hoskins Director Children, Young People and Families Public Health England May 2013 Mission Public Health England
More informationNAT submission to inquiry into the use of Immigration Detention
NAT submission to inquiry into the use of Immigration Detention 1. NAT (National AIDS Trust) welcomes the opportunity to submit evidence to this inquiry into the use of immigration detention. 2. NAT is
More informationPrEP (Pre-Exposure-Prophylaxis) for sub-saharan African migrants in Europe?
PrEP (Pre-Exposure-Prophylaxis) for sub-saharan African migrants in Europe? OFFERING PrEP TO ALL GROUPS AT INCREASED RISK FOR HIV. A RESEARCH AGENDA Jasna Loos HIV and Sexual Health Department of Public
More informationPartnerships between UNAIDS and the Faith-Based Community
Partnerships between UNAIDS and the Faith-Based Community Sally Smith- Partnership Adviser. Micah Network: Global Consultation-Churches Living with HIV Pattaya Thailand October 2008 UNAIDS Summary of 2008
More information39th Meeting of the UNAIDS Programme Coordinating Board Geneva, Switzerland. 6-8 December 2016
8 December 2016 39th Meeting of the UNAIDS Programme Coordinating Board Geneva, Switzerland 6-8 December 2016 Decisions The UNAIDS Programme Coordinating Board, Recalling that all aspects of UNAIDS work
More informationGLOBAL AIDS RESPONSE PROGRESS REPORTING (GARPR) 2014 COUNTRY PROGRESS REPORT SINGAPORE
GLOBAL AIDS RESPONSE PROGRESS REPORTING (GARPR) 2014 COUNTRY PROGRESS REPORT SINGAPORE Reporting period: January 2011 June 2013 Submission date: April 2014 I. Status at a glance Singapore s HIV epidemic
More informationVersion for the Silent Procedure 29 April Agenda item January Hepatitis
Version for the Silent Procedure 29 April 2014 134th session EB134.R18 Agenda item 10.5 25 January 2014 Hepatitis The Executive Board, Having considered the report on hepatitis, 1 RECOMMENDS to the Sixty-seventh
More informationHIV & AIDS IN SOUTH AFRICA: WHERE ARE WE AND WHAT ARE
HIV & AIDS IN SOUTH AFRICA: WHERE ARE WE AND WHAT ARE THE REMAINING CHALLENGES DR YOGAN PILLAY, NDOH SA HIV CLINICIANS SOCIETY CONFERENCE, CAPE TOWN 25 NOVEMBER, 2012 GLOBAL DATA 34m people living with
More informationKENYA AIDS STRATEGIC FRAMEWORK 2014/ /2019
KENYA AIDS STRATEGIC FRAMEWORK 2014/2015-2018/2019 2 Kenya Aids Strategic Framework 2014/2015 2018/2019 1. Introduction The Kenya AIDS Strategic Framework (KASF 2014/15 2018/19) has been developed in the
More informationFAST-TRACK COMMITMENTS TO END AIDS BY 2030
FAST-TRACK COMMITMENTS TO END AIDS BY 2030 FAST-TRACK COMMITMENTS TO END AIDS BY 2030 90-90-90 1 Ensure that 30 million people living with HIV have access to treatment through meeting the 90 90 90 targets
More informationThey are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:
Strategy,, policy and commissioning on hepatitis B and C testing NICE Pathways bring together everything NICE says on a topic in an interactive flowchart. NICE Pathways are interactive and designed to
More informationHIV Prevention Prioritization & Implementation Brief: Anambra State
HIV Prevention Prioritization & Implementation Brief: Anambra State Introduction The HIV epidemic in Nigeria is complex, with substantial heterogeneity in HIV prevalence across different regions and diverse
More informationItem 4. Sexual Health and Blood Borne Virus Strategy Strategy for Sexual Health and Blood Borne Viruses. Background
Item 4 Strategy for Sexual Health and Blood Borne Viruses Background 1. In August 2011 the Scottish Government launched a joint Sexual Health and Blood Borne Virus Framework. This brought four policy areas
More informationART for prevention the task ahead
ART for prevention the task ahead Dr Teguest Guerma WHO/HQS WHO's role and vision Status of the epidemic Overview Progress and challenges in treatment and prevention scale up ART for prevention Questions
More informationMultiple choice questions: ANSWERS
Multiple choice questions: ANSWERS Chapter 1. Diagnosis and promotion of serostatus awareness in sub-saharan Africa 1. Antiretroviral therapy reduces HIV transmission from a HIV- positive person to a susceptible
More informationHIV Prevention Prioritization & Implementation Brief: Gombe State
HIV Prevention Prioritization & Implementation Brief: Gombe State Introduction The HIV epidemic in Nigeria is complex, with substantial heterogeneity in HIV prevalence across different regions and diverse
More informationSexual and Reproductive Health and HIV. Dr. Rita Kabra Training course in Sexual and Reproductive Health Research Geneva 2012
Sexual and Reproductive Health and HIV Dr. Rita Kabra Training course in Sexual and Reproductive Health Research Geneva 2012 Global estimates of HIV-(2009) People living with HIV 33.3 million [31.4 35.3
More informationHIV PREVENTION: NHAS TO HIP
HIV PREVENTION: NHAS TO HIP Vasavi Thomas, RPh, MPH Public Health Advisor, Prevention Program Branch Division of HIV/AIDS Prevention Centers for Disease Control OVERVIEW National HIV/AIDS Strategy (NHAS)
More informationStrategic use of antiretroviral drugs to prevent HIV transmission
Strategic use of antiretroviral drugs to prevent HIV transmission 22th Tunisian Congress of Infectious Diseases 2nd Congress of Federation of Arab Societies of Clinical Microbiology and Infectious Diseases
More informationNew England HIV Implementation Science Network
Common Interests/Questions/Discussion Points across the Network Work Groups Identified In the First and Second Web Meeting Summaries (December 2014 January 2015) Key population: men who have sex with men
More informationHIV AND AIDS FACT SHEETS
The Human Immunodeficiency Virus (HIV) has been one of the most devastating new diseases to emerge over the course of the past century. Even though HIV may not always be in the headlines now, it is still
More informationThe current status of PrEP in Europe. Pep Coll AIDS Research Institute-IrsiCaixa Fight AIDS Foundation BCN Checkpoint
The current status of PrEP in Europe Pep Coll AIDS Research Institute-IrsiCaixa Fight AIDS Foundation BCN Checkpoint DISCLOSURES I have received a research grant from Gilead Sciences awarded to my institution
More informationEradicating cervical cancer. Our role in making it a reality
Eradicating cervical cancer Our role in making it a reality An estimated 49,000 women are living with or beyond a cervical cancer diagnosis Each year 3,200 women are diagnosed with cervical cancer and
More informationHIV Prevention Prioritization & Implementation Brief: Lagos State
HIV Prevention Prioritization & Implementation Brief: Lagos State Introduction The HIV epidemic in Nigeria is complex, with substantial heterogeneity in HIV prevalence across different regions and diverse
More informationTowards universal access
Key messages Towards universal access Scaling up priority HIV/AIDS interventions in the health sector September 2009 Progress report Towards universal access provides a comprehensive global update on progress
More informationPositive Women, Positive Midwifery
Positive Women, Positive Midwifery Caring for Women with HIV in Pregnancy: An Ethical Perspective Abena Addo MA(ethics) PDGE BSc RGN RM The School of Nursing and Midwifery UN Global targets(2011) 1. Halve
More informationConsultation on the Draft National Strategies for Blood Borne Viruses and Sexually Transmissible Infections
Consultation on the Draft National Strategies for Blood Borne Viruses and Sexually Transmissible Infections AFAO comments on draft Third National Sexually Transmissible Infections Strategy 2014 2017 AFAO
More informationAWP Five Year Strategy. An invitation to comment and get involved October 2017
AWP Five Year Strategy An invitation to comment and get involved October 2017 Transforming the future of AWP AWP has embarked upon an ambitious plan to transform the organisation, working in partnership
More informationWhich Scale Up Strategies/Programmatic Mixes are most Cost-Effective? Iris Semini UNAIDS May 2018
Which Scale Up Strategies/Programmatic Mixes are most Cost-Effective? Iris Semini UNAIDS May 2018 Outline Scaling up for Impact Critical Point of the Response Choices of strategies Accelerating Implementation
More informationEnding The HIV/AIDS Epidemic in America
Ending The HIV/AIDS Epidemic in America Unique Moment in History Media inquiries: Matt Matassa 703.647.1909; mmatassa@fhi.org FOR IMMEDIATE RELEASE: Thursday, 12 May 2011, 11 am EST Initiation of Antiretroviral
More informationENDING THE EPIDEMICS: A NATIONAL, STATE, AND CITY APPROACH
ENDING THE EPIDEMICS: A NATIONAL, STATE, AND CITY APPROACH Murray Penner Executive Director MISSION AND VISION READY TO END THE EPIDEMICS NASTAD s vision is a world free of HIV and viral hepatitis. NASTAD
More informationHIV surveillance in Northern Ireland 2016
HIV surveillance in Northern Ireland 2016 Contents Page 1 Surveillance arrangements 3 2 Introduction and key points 4 3 Trend information 5 - New diagnoses Age and gender Route of transmission CD4 surveillance
More informationA/59/CRP.2. Summary * * 24 March Original: English
24 March 2005 Original: English Fifty-ninth session Agenda item 43 Follow-up to the outcome of the twenty-sixth special session: implementation of the Declaration of Commitment on HIV/AIDS High-level meeting
More informationGetting To Zero A Framework to Eliminate HIV in Illinois
Getting To Zero A Framework to Eliminate HIV in Illinois Getting to Zero Exploratory Workgroup What will get Illinois to Zero? Now is the time for Illinois to build on the state s tremendous progress in
More informationThresia Sebastian MD, MPH University of Colorado, Denver Global Health Disasters Course October 2016
Thresia Sebastian MD, MPH University of Colorado, Denver Global Health Disasters Course October 2016 1 Objectives of today s lecture Describe global goals in the fight against HIV Review the epidemiology
More informationHealthy Mind Healthy Life
Healthy Mind Healthy Life onyourmind.org.uk A plan to support children and young people s emotional wellbeing and mental health in Wiltshire Children & Young People s Trust Our Vision This is a plan that
More informationHigher National Unit specification. General information. Unit title: HIV: An Introduction (SCQF level 7) Unit code: HG3N 34. Unit purpose.
Higher National Unit specification General information Unit code: HG3N 34 Superclass: PA Publication date: August 2016 Source: Scottish Qualifications Authority Version: 01 Unit purpose This Unit is designed
More informationHIV AND PEOPLE WHO INJECT DRUGS
UNAIDS 2017 HIV AND PEOPLE WHO INJECT DRUGS People who use and inject drugs are among the groups at highest risk of exposure to HIV, but remain marginalized and out of reach of health and social services.
More informationInfectious Diseases and Sexual Health in Southwark
Chapter 7 Infectious Diseases and Sexual Health in Southwark Introduction 7.1 The JSNA 2008 did not reflect the problems of infectious diseases and this chapter redresses this gap. Infectious diseases
More informationNeedle and Syringe Programs - 17 October 2013
Needle and Syringe Programs - 17 October 2013 ANCD Position Paper: Needle and Syringe Programs MEDIA RELEASE 17 October 2013 The Australian National Council on Drugs (ANCD) has today released a position
More informationYoung People. & Brexit. New Age for. democracy. Our. Living. Minds. Wage for Everyone. Matter. Save our. Youth. Teach. Services. First Aid.
Young People & Brexit 16: A New Age for 2017 Our Minds Matter democracy Living Wage for Everyone Save our Youth Services Teach First Aid in Schools Contents A manifesto by young people calling for action...
More informationUNAIDS 2018 THE YOUTH BULGE AND HIV
UNAIDS 218 THE YOUTH BULGE AND HIV UNAIDS Explainer THE YOUTH BULGE AND HIV In many sub-saharan African countries, declines in child mortality combined with a slow decline in fertility have resulted in
More informationHIV Pre-Exposure Prophylaxis (HIV PrEP) in Scotland. An update for registered practitioners September 2017
HIV Pre-Exposure Prophylaxis (HIV PrEP) in Scotland An update for registered practitioners September 2017 Key Messages HIV is a major public health challenge for Scotland with an annual average of 359
More informationHIV Prevention Prioritization & Implementation Brief: Benue State
HIV Prevention Prioritization & Implementation Brief: Benue State Introduction The HIV epidemic in Nigeria is complex, with substantial heterogeneity in HIV prevalence across different regions and diverse
More informationNational Dementia Vision for Wales Dementia Supportive Communities
National Dementia Vision for Wales Dementia Supportive Communities Crown Copyright 2011 WAG11-11223 F641 Introduction In Wales, we are justifiably proud of the communities we have built, just as we are
More informationTRANSITIONING FROM DONOR SUPPORT FOR TB & HIV IN EUROPE
TRANSITIONING FROM DONOR SUPPORT FOR TB & HIV IN EUROPE BULGARIA: CONTRACTING NGOs FOR BETTER RESULTS 1 CONTEXT Bulgaria has been a member state of the European Union (EU) since 2007 and is currently classified
More informationMortimer Market Centre, London. Dr Margaret Portman. Date : September 2016
Dr Mags Portman Mortimer Market Centre, London Speaker Name Statement Dr Margaret Portman None Declared Date : September 2016 PrEP - Tackling Implementation Dr Mags Portman Mortimer Market Centre 15 th
More informationOn the Fast-Track to end AIDS. HIV & AIDS in the Post 2015 Development Agenda
On the Fast-Track to end AIDS HIV & AIDS in the Post 2015 Development Agenda Miriam Maluwa Country Director, UNAIDS Ethiopia A i d & d e v e l o p m e n t S u m m i t A d d i s A b a b a 2-3 F e b r u
More informationA PAPER ON; EMPOWERMENT LEARNING STRATEGIES ON HIV/AIDS PREVENTION: THE CASE OF UGANDA
The Republic of Uganda A PAPER ON; EMPOWERMENT LEARNING STRATEGIES ON HIV/AIDS PREVENTION: THE CASE OF UGANDA By Hon: Bakoko Bakoru Zoë Minister of Gender, Labour and Social Development in The Republic
More informationMMWR Analysis Provides New Details on HIV Incidence in U.S. Populations
MMWR Analysis Provides New Details on HIV Incidence in U.S. Populations CDC HIV/AIDS Fa c t s S e p t e m b e r 2008 On August 6, 2008, the Centers for Disease Control and Prevention (CDC) released a new
More informationRegional Administration Officer Te Toka Centre JOB DESCRIPTION
Regional Administration Officer Te Toka Centre JOB DESCRIPTION March 2018 Location: Hours of Work: Responsible to: Direct Reports: Christchurch 30 Hours Te Toka Centre Manager None The New Zealand AIDS
More informationTrends in STDs: US Perspective. Michael Towns, M.D. WW Vice President, Medical Affairs BD Diagnostic Systems
Trends in STDs: US Perspective Michael Towns, M.D. WW Vice President, Medical Affairs BD Diagnostic Systems Outline Overview of STD Epidemiology and Current Situation in US Overview of Chlamydia infections
More informationViiV Healthcare s Position on Continuous Innovation in Prevention, Testing, Treatment & Care of HIV
ViiV Healthcare s Position on Continuous Innovation in Prevention, Testing, Treatment & Care of HIV ViiV Healthcare is a company 100% committed to HIV, and we are always looking to move beyond the status
More informationKigali Province East Province North Province South Province West Province discordant couples
EXECUTIVE SUMMARY This report summarizes the processes, findings, and recommendations of the Rwanda Triangulation Project, 2008. Triangulation aims to synthesize data from multiple sources to strengthen
More informationViiV Healthcare s Position on Funding and Investment in HIV
ViiV Healthcare s Position on Funding and Investment in HIV ViiV Healthcare is a company 100% committed to HIV, and we are always looking to move beyond the status quo and find new ways of navigating the
More informationGetting To Zero. A Framework to Eliminate HIV in Illinois. Getting to Zero Exploratory Workgroup. June 6, 2017
Getting To Zero A Framework to Eliminate HIV in Illinois Getting to Zero Exploratory Workgroup June 6, 2017 Note: This document was finalized in June of 2017, and does not contain the most recent statistics,
More informationHIV Treatment as Prevention (TasP)
HIV Treatment as Prevention (TasP) Last updated: April 3, 2019 Together, we can change the course of the HIV epidemic one woman at a time. #onewomanatatime #thewellproject What Is Treatment as Prevention?
More informationHIV in London: A Complexity Challenge
HIV in London: A Complexity Challenge Professor Jane Anderson (Homerton University Hospital) and Dr David Asboe (Chelsea and Westminster Hospital) NHS England Clinical Reference Group for HIV Representatives
More informationRectal Microbicides: The Basics. Date, Location Your name, Your affiliation
Rectal Microbicides: The Basics Date, Location Your name, Your affiliation This presentation Who is IRMA? Overview of the HIV epidemic New prevention technologies What are microbicides? Why do we need
More information